Alpha 2.0
Login Register
» Authors » C H van Gils

C H van Gils

Explore the profile of C H van Gils including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 1077
Followers 0
Related Specialties
Oncology
Public Health
Nutritional Sciences
Top 10 Co-Authors
P H M Peeters
E Riboli
A Trichopoulou
H Boeing
H B Bueno-de-Mesquita
F Clavel-Chapelon
D Palli
R Tumino
K Overvad
R Kaaks
Published In
Breast Cancer Res Treat
Eur J Clin Nutr
Ann Oncol
Br J Cancer
Cancer Causes Control
Affiliations
Soon will be listed here.
Recent Articles
1.
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis
Schaeffers A, Scholten H, van Beers M, Meussen B, Smid E, van Gils C, et al.
Oral Oncol . 2024 Aug; 157:106978. PMID: 39111144
Radiotherapy (RT) is a standard treatment for head and neck cancer (HNC) and chemoradiotherapy (CRT) is indicated for patients with locally advanced disease. Toxicities during treatment are common and can...
2.
Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
Ragusi M, van der Velden B, van Maaren M, van der Wall E, van Gils C, Pijnappel R, et al.
Breast Cancer Res Treat . 2022 Mar; 193(1):161-173. PMID: 35239071
Purpose: Although adjuvant systemic therapy (AST) helps increase breast cancer-specific survival (BCSS), there is a growing concern for overtreatment. By estimating the expected BCSS of AST using PREDICT, this study...
3.
Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data
El Sharouni M, Ahmed T, Witkamp A, Sigurdsson V, van Gils C, Nieweg O, et al.
Br J Surg . 2021 May; 108(5):550-553. PMID: 34043770
Background: Identifying patients with sentinel node (SN)-negative melanoma who are at greatest risk of recurrence is important. The European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group proposed...
4.
Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort
El Sharouni M, Varey A, Witkamp A, Ahmed T, Sigurdsson V, van Diest P, et al.
Br J Dermatol . 2021 Mar; 185(2):412-418. PMID: 33657653
Background: A nomogram to predict sentinel node (SN) positivity [the Melanoma Institute Australia (MIA) nomogram] was recently developed and externally validated using two large single-institution databases. However, there remains a...
5.
Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor
El Sharouni M, Stodell M, Ahmed T, Suijkerbuijk K, Cust A, Witkamp A, et al.
Ann Oncol . 2020 Nov; 32(3):375-383. PMID: 33253862
Background: It has been claimed, without supporting evidence, that knowledge of sentinel node (SN) status does not provide more accurate prognostic information than basic clinicopathological features of a primary cutaneous...
6.
Patient-reported cosmetic satisfaction and the long-term association with quality of life in irradiated breast cancer patients
Batenburg M, Gregorowitsch M, Maarse W, Witkamp A, Young-Afat D, Braakenburg A, et al.
Breast Cancer Res Treat . 2019 Oct; 179(2):479-489. PMID: 31650347
Purpose: To evaluate patient-reported cosmetic satisfaction in women treated with radiation therapy for breast cancer and to determine the association between dissatisfaction and quality of life (QoL) and depression. Methods:...
7.
Physical activity levels of women with breast cancer during and after treatment, a comparison with the Dutch female population
Gal R, Monninkhof E, Peeters P, van Gils C, van den Bongard D, Wendel-Vos G, et al.
Acta Oncol . 2019 Feb; 58(5):673-681. PMID: 30724657
Physical activity has been shown to reduce side-effects of breast cancer and its treatment. As physical activity levels of patients with breast cancer are largely unknown, we investigated these levels...
8.
Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts
de Lange S, Bakker M, Monninkhof E, Peeters P, de Koekkoek-Doll P, Mann R, et al.
Clin Radiol . 2018 May; 73(8):759.e1-759.e9. PMID: 29759590
Aim: To determine the willingness of women with extremely dense breasts to undergo breast cancer screening with magnetic resonance imaging (MRI) in a research setting, and to examine reasons for...
9.
Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients
Gregorowitsch M, van den Bongard H, Young-Afat D, Pignol J, van Gils C, May A, et al.
Breast Cancer Res Treat . 2017 Sep; 167(1):205-213. PMID: 28894982
Purpose: Ductal carcinoma in situ (DCIS) is associated with an excellent prognosis; historical studies have shown similar levels of psychological distress in patients with DCIS and with early-stage invasive breast...
10.
The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands
Kuijer A, Verloop J, Visser O, Sonke G, Jager A, van Gils C, et al.
Ann Oncol . 2017 May; 28(8):1970-1978. PMID: 28459994
Background: We aimed to assess whether socioeconomic status (SES) and ethnicity affect adjuvant systemic therapy (AST) guideline adherence in early breast cancer patients in a health care setting with assumed...